TR201620151A2 - Tadalafi̇l ve dapokseti̇n i̇çeren oral farmasöti̇k bi̇leşi̇mler - Google Patents

Tadalafi̇l ve dapokseti̇n i̇çeren oral farmasöti̇k bi̇leşi̇mler

Info

Publication number
TR201620151A2
TR201620151A2 TR2016/20151A TR201620151A TR201620151A2 TR 201620151 A2 TR201620151 A2 TR 201620151A2 TR 2016/20151 A TR2016/20151 A TR 2016/20151A TR 201620151 A TR201620151 A TR 201620151A TR 201620151 A2 TR201620151 A2 TR 201620151A2
Authority
TR
Turkey
Prior art keywords
dapoxetine
pharmaceutical compositions
oral pharmaceutical
tadalafil
tadalafil oral
Prior art date
Application number
TR2016/20151A
Other languages
English (en)
Inventor
Güner Di̇cle
Palantöken Arzu
Türkyilmaz Ali̇
Yelken Gülay
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2016/20151A priority Critical patent/TR201620151A2/tr
Publication of TR201620151A2 publication Critical patent/TR201620151A2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Abstract

Mevcut buluş, tadalafil veya onun farmasötik olarak kabul edilebilir bir tuzunu, solvatını veya polimorfunu, dapoksetin veya onun farmasötik olarak kabul edilebilir bir tuzu, solvatı veya polimorfu ile kombinasyon halinde içeren farmasötik bileşimler ile ilgilidir.
TR2016/20151A 2016-12-30 2016-12-30 Tadalafi̇l ve dapokseti̇n i̇çeren oral farmasöti̇k bi̇leşi̇mler TR201620151A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2016/20151A TR201620151A2 (tr) 2016-12-30 2016-12-30 Tadalafi̇l ve dapokseti̇n i̇çeren oral farmasöti̇k bi̇leşi̇mler

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TR2016/20151A TR201620151A2 (tr) 2016-12-30 2016-12-30 Tadalafi̇l ve dapokseti̇n i̇çeren oral farmasöti̇k bi̇leşi̇mler
EP17211085.0A EP3342403A1 (en) 2016-12-30 2017-12-29 Oral pharmaceutical compositions comprising tadalafil and dapoxetine
PCT/EP2017/084827 WO2018122384A1 (en) 2016-12-30 2017-12-29 Oral pharmaceutical compositions comprising tadalafil and dapoxetine

Publications (1)

Publication Number Publication Date
TR201620151A2 true TR201620151A2 (tr) 2018-07-23

Family

ID=60915386

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2016/20151A TR201620151A2 (tr) 2016-12-30 2016-12-30 Tadalafi̇l ve dapokseti̇n i̇çeren oral farmasöti̇k bi̇leşi̇mler

Country Status (3)

Country Link
EP (1) EP3342403A1 (tr)
TR (1) TR201620151A2 (tr)
WO (1) WO2018122384A1 (tr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019074464A3 (en) * 2017-10-09 2019-05-31 Montero Gida Sanayi Ve Ticaret Anonim Sirketi The pharmaceutical combination comprising dapoxetine and phosphodiesterase type-5

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109662950A (zh) * 2018-07-09 2019-04-23 华控创新(北京)药物研究院有限公司 一种含有盐酸达泊西汀的药物组合物
US10744137B1 (en) * 2020-01-06 2020-08-18 King Abdulaziz University Liquisolid tablet containing combined dose of tadalafil and dapoxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299712B6 (cs) 1999-09-03 2008-10-29 Apbi Holdings, Llc Použití dapoxetinu pro zvládnutí sexuální dysfunkce podáváním zpusobem podle potreby
EP2316435A1 (en) * 2009-10-22 2011-05-04 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical compositions of PDE-5 inhibitors and dapoxetine
US8202525B2 (en) 2009-12-22 2012-06-19 Pondera Biotechnologies, LLC Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
US20150216798A1 (en) * 2012-08-17 2015-08-06 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Novel orally administered pharmaceutical formulations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019074464A3 (en) * 2017-10-09 2019-05-31 Montero Gida Sanayi Ve Ticaret Anonim Sirketi The pharmaceutical combination comprising dapoxetine and phosphodiesterase type-5

Also Published As

Publication number Publication date
WO2018122384A1 (en) 2018-07-05
EP3342403A1 (en) 2018-07-04

Similar Documents

Publication Publication Date Title
NO2015020I2 (no) Ceritinib eller et farmasøytisk akseptabelt salt derav
CL2016002148A1 (es) Derivados de fenilen-1,5-diamina 2,4-disustituidos y aplicaciones de los mismos, y composiciones farmacéuticas y composiciones farmacéuticamente aceptables preparadas a partir de los mismos.
CL2014003136A1 (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos; composicion farmaceutica que los contiene y usos.
TR201816620T4 (tr) Kalp kapağı protezi iletim tertibatı.
BR112015022191A8 (pt) heteroaryl compounds and uses thereof
CY1119974T1 (el) Στερεες μορφες 3-(5-αμινο-2-μεθυλ-4-οξο-4η-κιναζολιν-3-υλ)-πιπεριδινο-2,6-διονης και φαρμακευτικες συνθεσεις και χρησεις αυτης
NO2016009I1 (no) Sakubitril/valsartan, inkludert farmasøytisk akseptable salter derav
ITUB20154132A1 (it) Maschera per uso subacqueo, in particolare di tipo granfacciale.
CY1118172T1 (el) Εισπνευστικη συσκευη
PE20150892A1 (es) Anticuerpos anti-notch y conjugados de anticuerpo-farmaco
CL2016000257A1 (es) Composiciones edulcorantes.
AR101995A1 (es) COMPUESTOS ANTAGONISTAS DE INTEGRINA avb6
UY34220A (es) Indazoles, composiciones farmacéuticas y uso de los mismos
ECSP13012788A (es) Derivados de biciclo[3,2,1]octilamida y sus usos
CL2013001338A1 (es) Compuestos derivados de benzotieno-piridinas sustituidas, inhibidores de la replicacion del vih; composicion farmaceutica que los comprende; combinacion farmaceutica; kit farmaceutico; y su uso para el tratamiento del vih.
DOP2016000298A (es) Pirazolopiridinas y pirazolopirimidinas
CL2012000772A1 (es) Compuestos derivados de hetorociclos carboxamidicos sustituidos, antagonista ar; composición farmacéutica que los comprende; y uso en el tratamiento del cáncer de próstata.
CL2016000117A1 (es) Autotaxina inhibidores comprende un anillo heteroaromático-bencilamina ciclo basico
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
CL2017003402A1 (es) Derivado de glucagón y una composición que comprende un conjugado de acción prolongada del mismo
CL2014000956A1 (es) Compuestos derivados de (4-fenilimidazol-2-il)etilamina, como moduladores de canal de sodio; composicion farmaceutica que los comprende; y su uso en el tratamiento del dolor.
ECSP11011054A (es) Péptidos antivirales terapéuticos
CL2016000258A1 (es) Composiciones edulcorantes.
CL2012002945A1 (es) Compuestos derivados de amino-piridazinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras.
UY35488A (es) Xantinas sustituidas y métodos para su uso